LOGIN  |  REGISTER
Recursion
Amneal Pharmaceuticals

Owlet to Participate in Cowen’s 2023 43rd Annual Health Care Conference

March 01, 2023 | Last Trade: US$6.95 0.11 -1.56

LEHI, Utah / Mar 01, 2023 / Business Wire / Owlet, Inc. (“Owlet”) (NYSE: OWLT) today announced that it will participate in the Cowen 43rd Annual Health Care Conference taking place on March 6-8, 2023 at the Boston Marriott Copley Place in Boston, Massachusetts. Kurt Workman, Owlet’s Co-Founder, President and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, are scheduled to present at the conference on Tuesday, March 7 at 1:30 p.m. EST. A link to the live webcast of the fireside chat will be available on the Owlet Investor Relations website, investors.owletcare.com. A replay of the webcast will also be available on Owlet’s Investor Relations website.

About Owlet, Inc.

Owlet was founded by a team of parents in 2012. Owlet’s mission is to empower parents with the right information at the right time, to give them more peace of mind and help them find more joy in the journey of parenting. Owlet’s digital parenting platform aims to give parents real-time data and insights to help parents feel more calm and confident. Owlet believes that every parent deserves peace of mind and the opportunity to feel their well-rested best. To learn more, visit www.owletcare.com.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page